Roselabs Finance is currently trading at Rs. 12.95, up by 0.34 points or 2.70 % from its previous closing of Rs. 12.61 on the BSE.
The scrip opened at Rs. 13.23 and has touched a high and low of Rs. 13.23 and Rs. 12.51 respectively. So far 1180 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 15.50 on 28-May-2013 and a 52 week low of Rs. 3.62 on 03-Jul-2012.
Last one week high and low of the scrip stood at Rs. 12.90 and Rs. 11.71 respectively. The current market cap of the company is Rs. 12.95 crore.
The promoters holding in the company stood at 57.64% and Non-Institutions held 42.36%.
Roselabs Group's Firms, Roselabs Bioscience and Roselabs Polymers have invested over Rs 400 crore to set up 'pre-filled syringes' (PFS) making facility near Ahmedabad with a capacity to manufacture 8 lakh syringes per day. The company’s facility near Ahmedabad has capabilities to make both glass and polymer (Cyclic Olefin Copolymer) syringes.
The two companies, which target Rs 100 crore turnover by this fiscal year end, so far, have commercialized 26 products in the PFS segment in India.
Roselab Biosciences, which manufactures glass pre-filled syringes, pre-fillable syringes, formulations and cytotoxic Active Pharmaceutical Ingredients (API) and Roselab Polymers, which delivers sterile, clean and ready to fill pre-fillable polymer syringes, are the group companies of Roselabs.
| Company Name | CMP |
|---|---|
| Bajaj Finance | 908.70 |
| Shriram Finance | 1036.50 |
| Aditya Birla Capital | 340.20 |
| Chola Invest & Fin. | 1579.65 |
| Tata Capital | 337.60 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: